health
EMA plans roadmap to address gaps in medicines development for women
The European Medicines Agency plans to publish a roadmap by the end of 2026 to improve how women’s health is considered in medicines development and regulation. Ten proposed priorities include better clinical-trial representation, stronger evidence and clearer communication of benefits and risks.